CYTK
#876
Cytokinetics, Incorporated - Common Stock
77.9 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.64%
Monthly Change
-2.34%
6 month change
+26.42%
Year Change
+34.08%
Previous Close
79.2 0
Open
77.9 0
Low
77.9 0
High
77.9 0
Volume
170
Financials
- Market Capitalization 10.83 B
- Employee 673
- Founded 1997
- CEO Robert I. BlumRobert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.72
Price to sales ratio
0.09
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 852 |  SMMT Summit Therapeutics Inc. - Common Stock | 14.33 USD | +0.70% | +12.83% | +13.64% | -27.84% | 11.43 B USD | ||
| 857 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | +0.12% | +0.19% | +0.47% | +33.83% | 11.36 B USD | ||
| 880 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 206.27 USD | -0.42% | -0.46% | -12.56% | +58.43% | 10.80 B USD | ||
| 896 |  KRYS Krystal Biotech, Inc. - Common Stock | 357.46 USD | -0.64% | +5.93% | -1.23% | +91.02% | 10.58 B USD |
Frequently asked questions about Cytokinetics Inc.
What is the Cytokinetics Inc. stock price today?
The current price of Cytokinetics Inc. (CYTK) is 77.9. Over the past 24 hours, the stock has changed by -1.64%. Follow the CYTK chart for real-time price dynamics.
What is the stock ticker of Cytokinetics Inc.?
Cytokinetics Inc. trades under the ticker CYTK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytokinetics Inc. stock going up?
CYTK has changed by +0.78% over the last week, -2.34% over the last month, and +34.08% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cytokinetics Inc.?
Cytokinetics Inc. currently has a market capitalization of 10.83 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cytokinetics Inc. earnings last quarter?
Last quarter, Cytokinetics Inc. reported earnings of -1.5 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cytokinetics Inc. revenue for the last quarter?
Cytokinetics Inc. reported quarterly revenue of 28.62 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cytokinetics Inc. net income for the last quarter?
Cytokinetics Inc. reported net income of -198.76 M for the last quarter. The previous quarter showed -206.03 M, which means net income changed by +3.53%.
How many employees does Cytokinetics Inc. have?
As of the latest available data, Cytokinetics Inc. has 673 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytokinetics Inc. EBITDA?
Cytokinetics Inc. EBITDA is -175.54 M, and its EBITDA margin is -613.27%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytokinetics Inc. stock?
You can buy Cytokinetics Inc. (CYTK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytokinetics Inc. stock?
Investing in Cytokinetics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CYTK chart and related analysis on metatrader.com as part of your research.